openPR Logo
Press release

Brain Tumor Therapeutics Market to Reach USD 6.84 Billion by 2034

11-13-2025 10:59 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Brain Tumor Therapeutics Market

Brain Tumor Therapeutics Market

Growing burden of malignant brain tumors, technological breakthroughs in targeted therapies, and expanding clinical trials in immuno-oncology accelerate global market growth.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49936

Introduction
The global Brain Tumor Therapeutics Market is undergoing significant transformation as advancements in immunotherapy, targeted drugs, and precision oncology reshape treatment outcomes for patients with malignant and non-malignant brain tumors. Rising incidence of glioblastoma multiforme (GBM), improved diagnostic imaging capabilities, and expanding access to neurosurgical care are fueling strong demand for innovative therapeutics. This press release presents the latest insights, key market dynamics, and forecast trends.

Key Takeaways
• Market Size 2024: USD 4.27 Billion
• Forecast for 2034: USD 6.84 Billion
• CAGR (2025-2034): 4.8%
• Top Therapies: Temozolomide, targeted kinase inhibitors, immune checkpoint inhibitors
• Fastest-growing Segment: Immunotherapy & gene-based treatments
• Most Prevalent Tumor Type: Glioblastoma (GBM)

Market Story
Brain tumors-particularly malignant gliomas-represent one of the most challenging areas in oncology. Glioblastoma alone accounts for nearly half of all malignant brain tumor cases worldwide, with limited treatment options and poor survival rates. As a result, clinical research efforts have intensified, focusing on novel mechanisms such as:
• Immunotherapy (PD-1/PD-L1 inhibitors, dendritic cell vaccines)
• Tumor Treating Fields (TTF)
• Gene therapy and viral vector-based approaches
• Targeted kinase inhibitors
• Precision oncology using genomic profiling

Advancements in MRI, AI-based tumor characterization, and biomarker-guided treatment selection are improving diagnosis and treatment personalization. Additionally, combination therapies (chemotherapy + TTF + immunotherapy) are gaining momentum for more effective outcomes.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49936/brain-tumor-therapeutics-market

Market Segments

By Tumor Type
• Glioblastoma Multiforme (GBM) - Largest & Most Critical Segment
• Astrocytoma
• Meningioma
• Pituitary Tumors
• Oligodendroglioma
• Other Primary Brain Tumors

By Therapy Type
• Chemotherapy (Temozolomide remains standard of care)
• Targeted Therapy (Kinase inhibitors, VEGF inhibitors)
• Immunotherapy (Fastest-growing; checkpoint inhibitors, vaccines)
• Radiation Therapy Adjuncts
• Tumor Treating Fields (TTF)
• Gene & Cell-based Therapies (Emerging)

By Route of Administration
• Oral
• Injectable
• Implantable (Biodegradable wafers, localized therapy)

By End User
• Hospitals & Oncology Centers
• Specialty Neurology Clinics
• Research Institutes & Clinical Trial Centers

By Region
• North America: Largest market due to advanced neuro-oncology infrastructure
• Europe: Strong clinical trial activity & biotech innovation
• Asia-Pacific: Fastest-growing due to rising diagnosis rates and enhanced treatment access
• South America & MEA: Increasing adoption of modern oncology therapies

Recent Developments
• 2024: New dendritic cell vaccines show promising results in recurrent GBM trials.
• 2025: AI-based diagnostic tools enhance early detection and refine treatment planning.
• 2023-2025: Expansion of tumor treating fields (TTF) adoption across major oncology centers.
• 2024: Novel gene therapy candidates targeting malignant gliomas enter Phase II trials.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49936

Expert Quote
"Brain tumor therapeutics are rapidly evolving, with immunotherapy and precision oncology opening new avenues for treatment. As clinical research accelerates, we expect more targeted and effective options to reach patients worldwide,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy

Key Market Drivers
• Rising global prevalence of brain tumors, especially glioblastoma
• Increased adoption of targeted & immuno-oncology therapies
• Advancements in MRI, AI imaging, and molecular diagnostics
• Expansion of neuroscience research and clinical trials
• Growing investments in personalized medicine
• Improved access to neurosurgical and oncology centers

Forecast & Future Outlook
The Brain Tumor Therapeutics Market will exceed USD 6.8 billion by 2034, driven by:
• Next-generation immunotherapies and vaccine platforms
• Wider use of genomic profiling for personalized treatment selection
• Growth of minimally invasive neurosurgical procedures
• Integration of digital pathology and AI-guided diagnostics
• Expansion of biotechnology pipelines targeting rare brain tumors
Future treatment landscapes will emphasize multi-modal therapy, precision targeting, and novel immunotherapy combinations to significantly improve survival outcomes.

Conclusion
The Brain Tumor Therapeutics Market is entering a transformative decade as medical innovation accelerates. Advances in immunotherapy, targeted agents, genomic medicine, and tumor-localized therapies are redefining care standards and offering renewed hope for patients with aggressive brain tumors.

This report is also available in the following languages : Japanese (脳腫瘍治療薬市場), Korean (뇌종양 치료제 시장), Chinese (脑肿瘤治疗市场), French (Marché des traitements contre les tumeurs cérébrales), German (Markt für Hirntumortherapeutika), and Italian (Mercato delle terapie per i tumori cerebrali), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49936

Our More Reports:

Dental Digital X Ray Market
https://exactitudeconsultancy.com/reports/49961/dental-digital-x-ray-market

Nebulizers Market
https://exactitudeconsultancy.com/reports/67002/nebulizers-market

Hospital Gowns Market
https://exactitudeconsultancy.com/reports/49966/hospital-gowns-market

Medical Gloves Market
https://exactitudeconsultancy.com/reports/49968/medical-gloves-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Brain Tumor Therapeutics Market to Reach USD 6.84 Billion by 2034 here

News-ID: 4268743 • Views:

More Releases from Exactitude Consultancy

Flexible Endoscopes Market is anticipated to reach over USD 5.7 billion by 2034
Flexible Endoscopes Market is anticipated to reach over USD 5.7 billion by 2034
The global Flexible Endoscopes Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 5.7 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 4.9% across the forecast period. North America leads the market, contributing roughly 40% of revenue, while the Asia-Pacific region is expected to grow fastest, with a projected CAGR of about 7.2%. The gastrointestinal endoscope segment holds
Medical Tape Market is anticipated to reach over USD 15.43 billion by 2029
Medical Tape Market is anticipated to reach over USD 15.43 billion by 2029
The medical tape market is estimated at approximately USD 9.42 billion in 2022 and is projected to reach around USD 15.43 billion by 2029, corresponding to a compound annual growth rate (CAGR) of about 5.64% from 2023 to 2029. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50174 Market Segmentation Highlights • By Product/Backing Material: Paper tapes, plastic (film) tapes, fabric tapes. • By Application: Wound care, surgical procedures, device fixation and monitoring, trauma/orthopedic settings. • By
Biomedical Refrigerators & Freezers Market to Reach USD 5.94 Billion by 2034
Biomedical Refrigerators & Freezers Market to Reach USD 5.94 Billion by 2034
Increasing global vaccination programs, growth of biopharmaceutical R&D, and rising need for blood, plasma, and specimen preservation are pushing strong market expansion across healthcare systems. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49931 Introduction The global Biomedical Refrigerators and Freezers Market is growing steadily as healthcare systems, research institutions, and biopharmaceutical companies invest heavily in high-performance cold storage solutions. These units are essential for maintaining the integrity of vaccines, blood products,
Biological Skin Substitutes Market is expected to grow to around USD 630 million by 2033
Biological Skin Substitutes Market is expected to grow to around USD 630 million …
The global biological skin substitutes market is estimated at just under USD 350 million in 2024 and is forecast to grow to approximately USD 630 million by 2033, which implies a compound annual growth rate (CAGR) of roughly 6.8% over the period. North America holds the largest share of the market currently, driven by advanced healthcare infrastructure and higher adoption of regenerative products. Major growth is expected from the Asia-Pacific

All 5 Releases


More Releases for Tumor

Evolving Market Trends In The Carcinoid Tumor Industry: Advancements In Neuroend …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Expected Carcinoid Tumor Market Size During the Forecast Period? In recent years, there has been a significant increase in the market size of carcinoid tumors, which is projected to expand from $1.61 billion in 2024 to $1.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%.
10-01-2024 | Health & Medicine
Getnews
Brain Tumor Foundation to Present Brain Tumor InfoCon, a Free Informational Prog …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1727733338.jpeg Brain Tumor Foundation October 8 online presentations to feature world's leading experts discussing topics ranging from neuro-oncology trials to targeting metabolism in glioblastoma and cytokine microdialysis NEW YORK - The Brain Tumor Foundation [https://www.braintumorfoundation.org/] (BTF), the nation's premier non-profit dedicated to providing support and guidance for brain tumor patients and their families, today announced that it will be presenting Brain Tumor InfoCon [https://braintumorfoundation.org/resources/2798-2/], a free informational program for patients and caregivers.
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949 This latest report researches the industry structure,
Global Wilms Tumor Market
Global Wilms Tumor Market Analysis and Insights The wilms tumor market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Ongoing research and products under clinical trials are the factors for the growth of the wilms tumor market. Request Access Global Wilms Tumor Market
Brain Tumor Treatment Market
Brain Tumor Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025 The global Brain Tumor Diagnosis and Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis and Treatments
Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the